Cardinal Health announced two tuck-in acquisitions to broaden its at-Home Solutions platform, purchasing AdaptHealth's Diabetes Health business and Strive Medical for about $360 million in cash. The deals extend diabetes and urology capabilities, building on the ADS integration progress and the ContinuCare Pathway program. Management expects the acquisitions to be EPS-accretive within the first year after close, signaling meaningful near-term margin and growth benefits if closing proceeds smoothly.
The deals are small relative to CAH; however, they expand a high-growth, cash-flow-positive segment, with explicit EPS accretion guidance within 12 months, suggesting a favorable re-rating if closing proceeds smoothly and integration milestones are met.
CAH is likely to achieve near-term EPS accretion from these tuck-ins within 12 months post-close, supporting a cautiously bullish stance pending deal closing and integration progress.
M&A / Corporate Developments: Demonstrates CAH's strategy to consolidate home-care, diabetes, and urology segments, reinforcing its leadership in at-Home Solutions and potential for EPS accretion via integration.